Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Evogene Ltd. (EVGN)

1.51   0.01 (0.67%) 11-19 11:05
Open: 1.51 Pre. Close: 1.5
High: 1.51 Low: 1.47
Volume: 9,053 Market Cap: 38M
Evogene Ltd is a biotechnology company for the improvement of crop productivity. It utilizes a proprietary integrated technology infrastructure to enhance seed traits underlying crop productivity.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.514 - 1.521 1.521 - 1.527
Low: 1.449 - 1.46 1.46 - 1.468
Close: 1.456 - 1.471 1.471 - 1.483

Technical analysis

as of: 2019-11-19 12:27:28 PM
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 1.87     One year: 1.97
Support: Support1: 1.45    Support2: 1.21
Resistance: Resistance1: 1.60    Resistance2: 1.69
Pivot: 1.53
Moving Average: MA(5): 1.49     MA(20): 1.55
MA(100): 1.58     MA(250): 1.85
MACD: MACD(12,26): -0.03     Signal(9): -0.03
Stochastic oscillator: %K(14,3): 25.49     %D(3): 16.92
RSI: RSI(14): 44.57
52-week: High: 2.65  Low: 1.34  Change(%): -39.6
Average Vol(K): 3-Month: 424  10-Days: 200

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
EVGN has closed above bottom band by 37.2%. Bollinger Bands are 5.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Lavie Bio Announces Advancement in Its Product Development Pipeline for Wheat Bio-stimulants
REHOVOT, Israel, Nov. 18, 2019 /PRNewswire/ -- Lavie Bio (Lavie), a subsidiary of Evogene (NASDAQ: EVGN) (TASE: EVGN), aiming to improve food quality, sustainability and agriculture productivity through the introduction of microbiome based ag-biological products, announces today phase…

Evogene Reports Third Quarter 2019 Financial Results
REHOVOT, Israel, Nov. 13, 2019 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading biotechnology company developing novel products for life science markets, announces today its financial results for the third quarter, ending September 30, 2019. Ofer Haviv, Evogene's…

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Global Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 25.75
Shares Float (M) 23.06
% Held by Insiders
% Held by Institutions
Shares Short (K) 11
Shares Short P. Month (K)

Stock Financials

EPS -0.715
Book Value (p.s.) 1.650
PEG Ratio
Profit Margin
Operating Margin -1280.29
Return on Assets (ttm) -20.3
Return on Equity (ttm) -36.1
Qtrly Rev. Growth -49.3
Gross Profit (p.s.) 0.011
Sales Per Share
EBITDA (p.s.) -0.676
Qtrly Earnings Growth
Operating Cash Flow (M) -16.18
Levered Free Cash Flow (M) -10.12

Stock Valuations

P/E -2.11
P/E Growth Ratio 0.03
P/BV 0.92
P/S 25.16
P/CF -2.40

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2013-11-19
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.